Related Articles
Metastatic Castration-Resistant Prostate Cancer: Addition of LuPSMA to Enzalutamide
An interim analysis of the Australian phase II ENZA-p trial showed that the addition of lutetium-177–labeled PSMA-617 (LuPSMA) to enzalutamide improved prostate-specific antigen progression-free survi…
Pediatric AML: Comparison of Induction Regimens
A phase III trial found that mitoxantrone-based induction resulted in better outcomes vs liposomal daunorubicin–based induction in pediatric patients with acute myeloid leukemia.
Cancer Screening Rates May Be Significantly Lower in U.S. Federally Qualified Health Centers
A recent cross-sectional study assessed the rates of breast, cervical, and colorectal cancer screenings in Federally Qualified Health Centers compared with overall screening rates in…
Aspirin Use Among Breast Cancer Survivors: Navigating Negative Results, Age, and Health Equity
Investigators uncovered critical issues related to health equity and aging that may have broad implications for cancer trials among breast cancer survivors receiving aspirin, according…
Pasi A. Jänne, MD, PhD, on NSCLC, Osimertinib, Chemotherapy: Update From FLAURA2
Pasi A. Jänne, MD, PhD, of Dana-Farber Cancer Institute, discusses an exploratory analysis from the FLAURA2 study, which indicates that baseline levels of plasma EGFR…
Immunotherapy Plus FOLFIRI for Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
In a French noncomparative phase II trial, investigators established limited activity of FOLFIRI (leucovorin, fluorouracil, and irinotecan) plus durvalumab or durvalumab/tremelimumab in the second-lin…
Kelly K. Hunt, MD, on Breast Cancer and Neoadjuvant Therapy: Expert Commentary
Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, discusses the benefits to patients with neoadjuvant therapy in advanced, inoperable breast…
Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk ALL
Exposure to propofol was associated with an increased risk of impairment in reaction time/processing speed at 1 year after treatment in children with high-risk B-cell…
Combination of Preketone Supplements and Immunotherapy May Be Effective in Patients With Prostate Cancer
A preclinical study suggests that the addition of a component of the ketogenic diet—a preketone dietary supplement—to immunotherapy may potentially be effective in treating prostate…
Kelly K. Hunt, MD, on Breast Cancer and Neoadjuvant Therapy: Expert Commentary
Kelly K. Hunt, MD, of The University of Texas MD Anderson Cancer Center, discusses the benefits to patients with neoadjuvant therapy in advanced, inoperable breast…